Pharmacist's Letter Canada | Convenient Monthly Updates + CE

Current Issue

November 2024 Issue

Be Ready to Vaccinate Patients on Immunosuppressants

Questions are coming up about how to vaccinate adults who are using immunosuppressive meds...

Resources

FAQ: Vaccinating Immunocompromised Patients
Chart: Flu Vaccines for 2024-25 (Canada)
Chart: COVID-19 Vaccines 2024-25 (Canada)
Chart: Preventing RSV
FAQ: Shingles Vaccine: FAQs
FAQ: HPV Vaccination
Chart: Comparison of Pneumococcal Vaccines

Help Your Patients Who Speak Limited English or French

About 20% of people in Canada have a first language other than English or French...

Pinpoint the Role of Quillivant ER for ADHD

Caregivers will ask you about Quillivant ER, the first long-acting methylphenidate in a chewable tab and oral suspension...

Stay On Top of New Treatments for Constipation in Children

Linaclotide (Constella) will be a new option to treat functional constipation in children age 6 to 17...

GO TO FULL ISSUE

CE & Training

INTERACTIVE SELF-STUDY CE: Influenza Immunization in Special Populations

CE-IN-THE-LETTER: Pharmacist's Letter Canada November 2024

LIVE CE: Pharmacy Essential Updates November 2024

PODCAST CE: Medication Talk - Implicit Bias in Healthcare

GO TO CE & TRAINING ORGANIZER >

Featured Clinical Resources

GO TO ALL CLINICAL RESOURCES >

What is Pharmacist's Letter Canada?

Pharmacist's Letter Canada is the resource trusted by over 200,000 pharmacists for staying current on medication recommendations and taking and tracking CE. Learn more >

Developing Your Pharmacy Career

Pharmacist's Letter Canada is one of many CE and training solutions from TRC Healthcare. We support pharmacists like you at all stages of their career. Learn more about:

Advanced Resources for Natural Medicines
Training on Diabetes Monitoring and Management for Pharmacists

Group Purchases & Pricing

Pharmacist’s Letter Canada is eligible for bulk discounts. Easily manage staff access and customize CE & training assignments. Bundle with other products for significant savings. Request information